Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT01525953
• Date of registration: 30/01/2012
• Prospective Registration: No
• Primary sponsor: Centre Oscar Lambret
• Public title: Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis CRCRT-EC
• Scientific title: Predictors of Survival for Complete Clinical Responders to Definite Chemoradiation or Radiation Therapy for Esophageal Cancer
• Date of first enrolment: January 2012
• Target sample size: 110
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT01525953
• Study type: Observational
• Study design: Observational Model: Cohort, Time Perspective: Retrospective
• Phase: N/A

Countries of recruitment

France

Contacts

• Name: Antoine ADENIS, MD, PhD
• Affiliation: Centre Oscar Lambret

Key inclusion & exclusion criteria

Inclusion Criteria:

- localized or locally advanced esophageal cancer

- patient who underwent definite chemoradiation or radiation

- patient with complete clinical response

Exclusion Criteria:

- metastatic disease



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Esophageal Cancer

Intervention(s)

Radiation: Radiotherapy

Drug: Chemotherapy

Primary Outcome(s)

Identification of prognostic factors for overall survival [Time Frame: From date of treatment until death, assessed up to 10 years]

Secondary Outcome(s)

Patterns of treatment failure [Time Frame: From date of treatment until treatment failure, assessed up to 10 years]

Disease-free survival [Time Frame: From date of treatment until progression or death, assessed up to 10 years]

Secondary ID(s)

CRCRT-EC

Source(s) of Monetary Support

Please refer to primary and secondary sponsors